Clinical Trial Update: Deep Learning for Automated Discrimination Between Stage T1-T2 and T3 Renal Cell Carcinoma on Contrast-Enhanced CT

View source ↗

Summary

This study is currently recruiting to evaluate a deep learning method that automatically discriminates between early-stage (T1-T2) and stage T3 renal cell carci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Peking University First Hospital | Conditions: Carcinoma, Renal Cell, Diagnostic Imaging | Status: RECRUITING